An Observational Clinical Study of the Efficacy and Tolerability of Donepezil in the Treatment of Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1421-9824|15|4|189-198

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.15, Iss.4, 2003-03, pp. : 189-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Donepezil for Alzheimer’s Disease in Clinical Practice – The DONALD Study

By  

Dementia and Geriatric Cognitive Disorders, Vol. 18, Iss. 1, 2004-06 ,pp. : 37-43

Karger

Access to resources Recommend Favorite

Clinical Efficacy and Safety of Donepezil on Cognitive and Global Function in Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 11, Iss. 6, 2000-10 ,pp. : 299-313

Karger

Access to resources Recommend Favorite

Donepezil in Alzheimer’s Disease: What to Expect after 3 Years of Treatment in a Routine Clinical Setting

By  

Dementia and Geriatric Cognitive Disorders, Vol. 23, Iss. 3, 2006-12 ,pp. : 150-160

Karger

Access to resources Recommend Favorite

Effect of the Apolipoprotein E ε4 Allele on the Efficacy and Tolerability of Galantamine in the Treatment of Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 21, Iss. 1, 2005-12 ,pp. : 33-39

Karger

Access to resources Recommend Favorite

Perspectives in the Management of Alzheimer’s Disease: Clinical Profile of Donepezil

By  

Dementia and Geriatric Cognitive Disorders, Vol. 9, Iss. 3, 1998-10 ,pp. : 29-42

Karger

Access to resources Recommend Favorite